| Clozapine | IC50 | 10.0 [1] |
| Clozapine | Ki | 15.85 [1], 21.0 [2], 73.0 [3] |
| Risperidone | IC50 | 1.81 [1], 7.0 [2] |
| Risperidone | Ki | 12.0 [1], 41.69 [2] |
| Serotonin | IC50 | 81.0 [1] |
| Serotonin | Ki | 8.3 [1] |
| Haloperidol | IC50 | 10000.0 [1] |
| Haloperidol | Ki | 4570.88 [1] |
| Olanzapine | Ki | 14.0 [1] |
| Aripiprazole | IC50 | 1380.0 [1] |
| CID 3693566 | IC50 | 1.5 [1], 2.7 [2], 5.5 [3], 8.3 [4] |
| CID 3693566 | Ki | 0.6 [1], 2.0 [2] |
| Mianserin | IC50 | 7.41 [1] |
| Mianserin | Ki | 4.4 [1], 8.0 [2] |
| Mesulergine | IC50 | 1.9 [1] |
| Mesulergine | Ki | 0.92 [1], 1.5 [2], 1.82 [3], 2.0 [4] |
| Volinanserin | Ki | 13.0 [1], 107.0 [2], 316.23 [3] |
| SB 243213 | IC50 | 0.7 [1] |
| SB 243213 | Ki | 1.0 [1] |
| Chlorpromazine | Ki | 2.74 [1], 27.0 [2], 30.0 [3], 39.81 [4] |
| Agomelatine | Ki | 630.0 [1], 707.95 [2], 708.0 [3] |
| 6-Chloro-5-methyl-1-((2-(2-methylpyrid-3-yloxy)pyrid-5-yl)carbamoyl)indoline | Ki | 1.0 [1] |
| Lorcaserin | Ki | 15.0 [1], 167.0 [2], 257.0 [3] |
| Benzo(1,2-b:4,5-b')dipyrrole-1(2H)-carboxamide, 3,5-dihydro-5-methyl-N-3-pyridinyl- | IC50 | 9.4 [1] |
| Benzo(1,2-b:4,5-b')dipyrrole-1(2H)-carboxamide, 3,5-dihydro-5-methyl-N-3-pyridinyl- | Ki | 10.0 [1], 12.59 [2] |
| (S)-2-(6-Chloro-5-fluoro-indol-1-yl)-1-methyl-ethylamine | Ki | 1.26 [1], 2.3 [2], 26.0 [3] |
| 1-(2,4-Difluorophenethyl)-4-(4-fluorophenylsulfonyl)piperidine | Ki | 39.0 [1], 92.0 [2] |
| 6-[[4-(6-Fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]methyl]-6,7-dihydro-5H-1-benzofuran-4-one | Ki | 338.84 [1], 3981.07 [2], 10000.0 [3], 18197.01 [4] |
| Ketanserin | IC50 | 2.7 [1] |
| Ketanserin | Ki | 43.65 [1], 100.0 [2] |
| Sumatriptan | IC50 | 7.3 [1], 7943.28 [2], 10000.0 [3] |
| Ritanserin | Ki | 1.8 [1], 1.9 [2] |
| Quipazine | IC50 | 61.66 [1] |
| Quipazine | Ki | 200.0 [1] |
| Sertindole | Ki | 0.2 [1], 1.0 [2], 1.3 [3] |
| 5-Carboxamidotryptamine | IC50 | 588.84 [1] |
| 5-Carboxamidotryptamine | Ki | 620.0 [1], 2511.89 [2] |
| alpha-Methyl-5-HT | Ki | 6.6 [1], 7.0 [2], 60.0 [3] |
| 5-Methoxy-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole | IC50 | 290.0 [1], 300.0 [2] |
| 5-Methoxy-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole | Ki | 400.0 [1] |
| 4-(4-Methylpiperazin-1-yl)-7-(trifluoromethyl)pyrrolo[1,2-a]quinoxaline | IC50 | 10000.0 [1], 97723.72 [2] |
| 5-Chloro-N-(4-methoxy-3-(piperazin-1-yl)phenyl)-3-methylbenzo[b]thiophene-2-sulfonamide | Ki | 530.0 [1], 776.25 [2], 1995.26 [3] |
| 1-(8-Bromo-2,3,6,7-tetrahydrobenzo[1,2-b:4,5-b']difuran-4-yl)propan-2-amine | Ki | 0.3 [1], 2.28 [2] |
| 4-Imidazolidinone, 5-((6-bromo-1H-indol-3-yl)methylene)-2-imino-1,3-dimethyl- | Ki | 330.0 [1], 1704.0 [2], 2202.0 [3] |
| (R)-8,9-Dichloro-2,3,4,4a-Tetrahydro-1H-Pyrazino[1,2-a]Quinoxalin-5(6H)-One | Ki | 3.0 [1], 3.3 [2], 32.0 [3] |
| N,N-Dimethyl-1-(3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl)methanamine | IC50 | 12.3 [1], 1000.0 [2] |
| 1-(2,4-Difluorophenethyl)-4-fluoro-4-(4-fluorophenylsulfonyl)piperidine | Ki | 69.0 [1], 176.0 [2], 180.0 [3] |
| 6-Chloro-5-methyl-N-pyridin-3-yl-2,3-dihydroindole-1-carboxamide | Ki | 6.3 [1], 6.31 [2] |
| 5-[2-[4-(6-Fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-6,7-dihydro-5H-1-benzofuran-4-one | Ki | 34.67 [1], 69.18 [2] |
| (7S)-7-[(5-Fluoro-2-methylphenyl)methoxy]-2-[(2R)-2-methylpiperazin-1-yl]-6,7-dihydro-5H-cyclopenta[b]pyridine | IC50 | 1.9 [1], 86.0 [2] |
| (7S)-7-[(5-Fluoro-2-methylphenyl)methoxy]-2-[(2R)-2-methylpiperazin-1-yl]-6,7-dihydro-5H-cyclopenta[b]pyridine | Ki | 1.5 [1] |
| N-[2-(1,3-Benzodioxol-5-yl)ethyl]-N-[2-(3,4-dimethoxyphenyl)ethyl]-3-phenylpropan-1-amine | IC50 | 12589.25 [1] |
| N-[2-(1,3-Benzodioxol-5-yl)ethyl]-N-[2-(3,4-dimethoxyphenyl)ethyl]-3-phenylpropan-1-amine | Ki | 399.0 [1] |
| Propranolol | IC50 | 5011.87 [1] |
| Propranolol | Ki | 1202.0 [1] |
| 8-OH-Dpat | Ki | 7250.0 [1], 14800.0 [2] |
| Spiperone | Ki | 630.96 [1], 1150.0 [2] |
| Methysergide | Ki | 1.09 [1], 2.5 [2] |
| Cyproheptadine | Ki | 1.28 [1], 11.0 [2] |
| Ketotifen | Ki | 84.0 [1], 199.53 [2] |
| Metergoline | Ki | 0.35 [1], 0.5 [2] |
| Rizatriptan | IC50 | 7943.28 [1], 10000.0 [2] |
| 1-(2-Methylbenzo[d]oxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea | Ki | 1200.0 [1], 5011.87 [2] |
| N,N-Dimethyl-5-methoxytryptamine | IC50 | 250.0 [1] |
| N,N-Dimethyl-5-methoxytryptamine | Ki | 42.0 [1] |
| 1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol | Ki | 716.0 [1], 1400.0 [2] |
| IB-Meca | Ki | 5420.0 [1] |
| (R)-3-((2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidin-1-yl)sulfonyl)phenol | Ki | 5.0 [1], 10000.0 [2] |
| Latrepirdine | Ki | 75.86 [1], 76.0 [2] |
| (R)-1-(4-Iodo-2,5-dimethoxyphenyl)propan-2-amine | Ki | 4.0 [1] |
| SB 204070 hydrochloride | Ki | 79.43 [1], 125.89 [2] |
| (Rac)-WAY-161503 | Ki | 4.0 [1], 58.0 [2] |
| SB 200646 hydrochloride | Ki | 109.65 [1], 138.04 [2] |
| Aplysinopsin | Ki | 10000.0 [1], 14451.0 [2] |
| 5-Methoxy-alpha-methyltryptamine | Ki | 8.3 [1] |
| N,N-Diallyl-5-methoxytryptamine | Ki | 457.09 [1], 1737.8 [2] |
| 1-[(1-(4-Chlorophenyl)-1H-pyrazol-4-yl)methyl]-4-phenylpiperazine | Ki | 8440.0 [1], 8630.0 [2] |
| (S)-2-(7-Ethyl-1H-furo(2,3-g)indazol-1-yl)-1-methylethylamine | Ki | 0.89 [1] |
| SB 221284 | Ki | 2.51 [1] |
| N-(3-(3-Pyridinyl)-5-fluorophenyl)-5-methoxy-6-(trifluoromethyl)indoline-1-carboxamide | IC50 | 10.0 [1] |
| N-(3-(3-Pyridinyl)-5-fluorophenyl)-5-methoxy-6-(trifluoromethyl)indoline-1-carboxamide | Ki | 1.0 [1] |
| CP-809101 | Ki | 1.0 [1], 9.3 [2] |
| Nelotanserin | Ki | 110.0 [1], 158.49 [2] |
| 8-(4-Benzylpiperazin-1-yl)-3-thia-1,7-diazatricyclo[7.3.0.02,6]dodeca-2(6),4,7,9,11-pentaene | IC50 | 1862.09 [1] |
| 4-[3-(4-Chlorophenyl)-3-hydroxy-8-azabicyclo[3.2.1]oct-8-yl]-1-(4-fluorophenyl)butan-1-one | Ki | 872.1 [1] |
| 3-[4-(4-Fluorobenzoyl)piperidinomethyl]tetralin-1-one | Ki | 234.42 [1], 489.78 [2] |
| 4-(3-(4-Chlorophenyl)-3-hydroxypyrrolidin-1-yl)-1-(4-fluorophenyl)butan-1-one | Ki | 1252.0 [1], 3598.0 [2] |
| 3-[4-(2-Methoxyphenyl)piperazinomethyl]tetralin-1-one | Ki | 2818.38 [1] |
| 2-[[4-(6-Fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]methyl]-1,2,3,9-tetrahydrocarbazol-4-one | Ki | 27.54 [1], 57.54 [2] |
| 6-[[4-(4-Fluorobenzoyl)piperidin-1-yl]methyl]-6,7-dihydro-5H-1-benzofuran-4-one | Ki | 1548.82 [1], 10000.0 [2] |
| 3-[[4-(6-Fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]methyl]-3,4-dihydro-2H-naphthalen-1-one | Ki | 104.71 [1], 128.82 [2] |
| 7-[4-[4-(2,3-Dichlorophenyl)-1,4-diazepan-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one | Ki | 0.6 [1], 115.0 [2] |
| 5-Chloro-N-[4-methoxy-3-(4-methylpiperazin-1-yl)phenyl]-3-methyl-1-benzothiophene-2-sulfonamide | Ki | 501.19 [1] |
| 1-(2,4-Difluorophenethyl)-4-(phenylsulfonyl)piperidine | Ki | 25.0 [1] |
| 2-[2-[4-[4-(4-Fluorophenyl)-4-oxobutyl]piperazin-1-yl]ethyl]-2,3-dihydroinden-1-one | Ki | 6165.95 [1], 10000.0 [2] |